Taiko Pharmaceutical Co.,Ltd. (4574.T) JPX

Currency In JPY

AD

Valuation

Market Cap14.97B
Enterprise Value11.53B
P/E Ratio18.92
PEG Ratio0.29
Price/Sales Ratio1.97
Price/Book Ratio1.55
Enterprise/Revenue1.59
Enterprise/EBITDA11.95

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.1
Operating Margin0.06
AD

Management Effectiveness

Return On Assets0.06
Return On Equity0.08

Income Statement

Revenue6.4B
Revenue/Share131.74
Gross Profit3.48B
EBITDA724M
Net Income923M
Diluted EPS18.37

Balance Sheet

Total Cash3.17B
Total Cash/Share62.99
Total Debt172M
Total Debt/Equity0.02
Current Ratio5.13
Book Value Per Share167.67

Price History

52-Week Change-7.5
52-Week High317
52-Week Low246
Moving Average 50 Days258.2
Moving Average 200 Days273.86

Statistics

Average Volume117,386
Shares Outstanding50.31M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate3.3
Trailing Annual Dividend Yield1.27
Payout Ratio0
Last Split Factor3:1
Last Split DateMarch 30, 2020
AD